Brilacidin has a history of success in human trials. Drano, to further expend on your post, we must not forget that Brilacidin has already been put into the bodies of over 460+ human beings as a part of other clinical indications. Those trials, along with the RBL Selectivity Index of 326, have now established Brilacidin's safety and efficacy. IMO, these facts make the Covid trials a mere formality.